| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 1.22e-08 | 3 | 47 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 2.39e-05 | 24 | 47 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 3.44e-05 | 27 | 47 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | L-lactate dehydrogenase activity | 5.40e-05 | 5 | 47 | 2 | GO:0004459 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 6.95e-05 | 34 | 47 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 7.59e-05 | 35 | 47 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | lactate dehydrogenase activity | 8.09e-05 | 6 | 47 | 2 | GO:0004457 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.09e-04 | 49 | 47 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.79e-04 | 54 | 47 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.27e-04 | 140 | 47 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 8.10e-04 | 18 | 47 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.11e-03 | 21 | 47 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.51e-03 | 115 | 47 | 3 | GO:0004497 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.90e-03 | 34 | 47 | 2 | GO:0046966 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.32e-06 | 10 | 47 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.32e-06 | 10 | 47 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | regulation of pronephros size | 5.08e-06 | 2 | 47 | 2 | GO:0035565 | |
| GeneOntologyBiologicalProcess | pronephros morphogenesis | 1.52e-05 | 3 | 47 | 2 | GO:0072114 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 1.66e-05 | 22 | 47 | 3 | GO:0019373 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.00e-05 | 906 | 47 | 10 | GO:0043009 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 3.71e-05 | 929 | 47 | 10 | GO:0009792 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 4.99e-05 | 430 | 47 | 7 | GO:0009100 | |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 5.25e-05 | 32 | 47 | 3 | GO:0035162 | |
| GeneOntologyBiologicalProcess | regulation of kidney size | 7.58e-05 | 6 | 47 | 2 | GO:0035564 | |
| GeneOntologyBiologicalProcess | liver development | 9.42e-05 | 202 | 47 | 5 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 1.01e-04 | 205 | 47 | 5 | GO:0061008 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 1.52e-04 | 357 | 47 | 6 | GO:0009101 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 1.82e-04 | 124 | 47 | 4 | GO:0001676 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.87e-04 | 713 | 47 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.05e-04 | 128 | 47 | 4 | GO:0033559 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 2.21e-04 | 731 | 47 | 8 | GO:0032787 | |
| GeneOntologyBiologicalProcess | regulation of vitamin D receptor signaling pathway | 2.26e-04 | 10 | 47 | 2 | GO:0070562 | |
| GeneOntologyBiologicalProcess | pronephros development | 2.26e-04 | 10 | 47 | 2 | GO:0048793 | |
| GeneOntologyBiologicalProcess | heme metabolic process | 2.54e-04 | 54 | 47 | 3 | GO:0042168 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.60e-04 | 561 | 47 | 7 | GO:0048568 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 2.64e-04 | 252 | 47 | 5 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 2.64e-04 | 252 | 47 | 5 | GO:0006486 | |
| GeneOntologyBiologicalProcess | bile acid metabolic process | 2.68e-04 | 55 | 47 | 3 | GO:0008206 | |
| GeneOntologyBiologicalProcess | embryo development | STK3 HOXB3 NCOA6 HNF1A HNF1B COL11A1 PAX7 MAN2A1 LDB1 MED1 CECR2 | 3.05e-04 | 1437 | 47 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | vitamin D receptor signaling pathway | 3.31e-04 | 12 | 47 | 2 | GO:0070561 | |
| GeneOntologyBiologicalProcess | primitive hemopoiesis | 3.31e-04 | 12 | 47 | 2 | GO:0060215 | |
| GeneOntologyBiologicalProcess | glycosylation | 3.63e-04 | 270 | 47 | 5 | GO:0070085 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound metabolic process | 4.00e-04 | 63 | 47 | 3 | GO:0006778 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.80e-04 | 67 | 47 | 3 | GO:0019748 | |
| GeneOntologyBiologicalProcess | response to cadmium ion | 5.01e-04 | 68 | 47 | 3 | GO:0046686 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 5.01e-04 | 68 | 47 | 3 | GO:0019369 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 5.45e-04 | 70 | 47 | 3 | GO:0060261 | |
| GeneOntologyBiologicalProcess | tetrapyrrole metabolic process | 6.17e-04 | 73 | 47 | 3 | GO:0033013 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 7.21e-04 | 77 | 47 | 3 | GO:2000144 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 7.47e-04 | 180 | 47 | 4 | GO:0120254 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 8.35e-04 | 81 | 47 | 3 | GO:0060260 | |
| GeneOntologyBiologicalProcess | placenta development | 1.04e-03 | 197 | 47 | 4 | GO:0001890 | |
| GeneOntologyBiologicalProcess | branch elongation of an epithelium | 1.14e-03 | 22 | 47 | 2 | GO:0060602 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.17e-03 | 525 | 47 | 6 | GO:0009410 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 1.17e-03 | 91 | 47 | 3 | GO:2000142 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 1.25e-03 | 93 | 47 | 3 | GO:0060415 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 1.25e-03 | 23 | 47 | 2 | GO:0071305 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.29e-03 | 94 | 47 | 3 | GO:0042440 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 1.29e-03 | 94 | 47 | 3 | GO:0045665 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | 1.30e-03 | 736 | 47 | 7 | GO:1901137 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.45e-03 | 750 | 47 | 7 | GO:0048729 | |
| GeneOntologyBiologicalProcess | lactate metabolic process | 1.47e-03 | 25 | 47 | 2 | GO:0006089 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.53e-03 | 1220 | 47 | 9 | GO:0051093 | |
| GeneOntologyBiologicalProcess | gland development | 1.60e-03 | 558 | 47 | 6 | GO:0048732 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.60e-03 | 376 | 47 | 5 | GO:0008202 | |
| GeneOntologyBiologicalProcess | regulation of TORC1 signaling | 1.63e-03 | 102 | 47 | 3 | GO:1903432 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 1.63e-03 | 102 | 47 | 3 | GO:0048644 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.87e-03 | 231 | 47 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | TORC1 signaling | 1.97e-03 | 109 | 47 | 3 | GO:0038202 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.00e-03 | 1269 | 47 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 2.15e-03 | 1035 | 47 | 8 | GO:0019752 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 2.23e-03 | 596 | 47 | 6 | GO:0001701 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 2.27e-03 | 31 | 47 | 2 | GO:0071295 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 2.35e-03 | 1299 | 47 | 9 | GO:1902533 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.39e-03 | 1053 | 47 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 2.47e-03 | 1058 | 47 | 8 | GO:0043436 | |
| GeneOntologyBiologicalProcess | embryonic placenta development | 2.52e-03 | 119 | 47 | 3 | GO:0001892 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 2.55e-03 | 1064 | 47 | 8 | GO:0006082 | |
| MousePheno | abnormal bile salt homeostasis | 1.14e-05 | 47 | 42 | 4 | MP:0005365 | |
| MousePheno | decreased intestinal cholesterol absorption | 1.67e-05 | 17 | 42 | 3 | MP:0002647 | |
| MousePheno | abnormal intestinal cholesterol absorption | 2.36e-05 | 19 | 42 | 3 | MP:0002645 | |
| MousePheno | abnormal intestinal lipid absorption | 1.07e-04 | 31 | 42 | 3 | MP:0005342 | |
| MousePheno | impaired placental function | 1.31e-04 | 6 | 42 | 2 | MP:0006372 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 5.58e-08 | 4 | 46 | 3 | IPR008067 | |
| Domain | HNF1_dimer_dom | 5.93e-06 | 2 | 46 | 2 | IPR023219 | |
| Domain | HNF1b_C | 5.93e-06 | 2 | 46 | 2 | IPR006897 | |
| Domain | HNF-1B_C | 5.93e-06 | 2 | 46 | 2 | PF04812 | |
| Domain | HNF-1_N | 1.78e-05 | 3 | 46 | 2 | IPR006899 | |
| Domain | HNF-1_N | 1.78e-05 | 3 | 46 | 2 | PF04814 | |
| Domain | L-lactate_DH | 5.91e-05 | 5 | 46 | 2 | IPR011304 | |
| Domain | L-lactate_DH_AS | 5.91e-05 | 5 | 46 | 2 | IPR018177 | |
| Domain | L_LDH | 5.91e-05 | 5 | 46 | 2 | PS00064 | |
| Domain | Ldh_1_N | 1.65e-04 | 8 | 46 | 2 | PF00056 | |
| Domain | L-lactate/malate_DH | 1.65e-04 | 8 | 46 | 2 | IPR001557 | |
| Domain | Lactate/malate_DH_N | 1.65e-04 | 8 | 46 | 2 | IPR001236 | |
| Domain | Cyt_P450_E_grp-I | 1.85e-04 | 45 | 46 | 3 | IPR002401 | |
| Domain | - | 2.11e-04 | 9 | 46 | 2 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 2.11e-04 | 9 | 46 | 2 | IPR022383 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 2.11e-04 | 9 | 46 | 2 | IPR015955 | |
| Domain | Ldh_1_C | 2.11e-04 | 9 | 46 | 2 | PF02866 | |
| Domain | Cyt_P450_CS | 3.00e-04 | 53 | 46 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 3.73e-04 | 57 | 46 | 3 | PS00086 | |
| Domain | - | 3.92e-04 | 58 | 46 | 3 | 1.10.630.10 | |
| Domain | p450 | 3.92e-04 | 58 | 46 | 3 | PF00067 | |
| Domain | Cyt_P450 | 4.34e-04 | 60 | 46 | 3 | IPR001128 | |
| Domain | - | 2.00e-03 | 27 | 46 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 2.31e-03 | 29 | 46 | 2 | IPR010982 | |
| Domain | Homeobox | 2.59e-03 | 234 | 46 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.68e-03 | 236 | 46 | 4 | PS00027 | |
| Domain | HOX | 2.72e-03 | 237 | 46 | 4 | SM00389 | |
| Domain | Homeobox_dom | 2.80e-03 | 239 | 46 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 2.80e-03 | 239 | 46 | 4 | PS50071 | |
| Domain | Spectrin/alpha-actinin | 2.81e-03 | 32 | 46 | 2 | IPR018159 | |
| Domain | SPEC | 2.81e-03 | 32 | 46 | 2 | SM00150 | |
| Domain | KH_1 | 3.94e-03 | 38 | 46 | 2 | PF00013 | |
| Domain | KH | 4.36e-03 | 40 | 46 | 2 | SM00322 | |
| Domain | KH_dom | 4.36e-03 | 40 | 46 | 2 | IPR004087 | |
| Domain | KH_TYPE_1 | 4.80e-03 | 42 | 46 | 2 | PS50084 | |
| Domain | - | 5.11e-03 | 283 | 46 | 4 | 1.10.10.60 | |
| Domain | KH_dom_type_1 | 5.26e-03 | 44 | 46 | 2 | IPR004088 | |
| Domain | TBC | 6.48e-03 | 49 | 46 | 2 | SM00164 | |
| Domain | RabGAP-TBC | 7.55e-03 | 53 | 46 | 2 | PF00566 | |
| Domain | TBC_RABGAP | 8.11e-03 | 55 | 46 | 2 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 8.11e-03 | 55 | 46 | 2 | IPR000195 | |
| Domain | Homeodomain-like | 8.90e-03 | 332 | 46 | 4 | IPR009057 | |
| Domain | USP_CS | 1.15e-02 | 66 | 46 | 2 | IPR018200 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.09e-06 | 11 | 34 | 3 | M27130 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.78e-06 | 12 | 34 | 3 | MM14847 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.02e-05 | 18 | 34 | 3 | MM14841 | |
| Pathway | REACTOME_XENOBIOTICS | 2.20e-05 | 23 | 34 | 3 | M5372 | |
| Pathway | REACTOME_XENOBIOTICS | 2.84e-05 | 25 | 34 | 3 | MM14846 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 5.62e-05 | 5 | 34 | 2 | M47808 | |
| Pathway | KEGG_N_GLYCAN_BIOSYNTHESIS | 1.81e-04 | 46 | 34 | 3 | M11079 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.47e-04 | 51 | 34 | 3 | M17726 | |
| Pathway | WP_NGLYCAN_BIOSYNTHESIS | 3.43e-04 | 57 | 34 | 3 | M48051 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 4.40e-04 | 62 | 34 | 3 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 4.83e-04 | 64 | 34 | 3 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.83e-04 | 64 | 34 | 3 | M9488 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.29e-04 | 66 | 34 | 3 | MM14839 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 5.81e-04 | 15 | 34 | 2 | MM1439 | |
| Pathway | REACTOME_FATTY_ACIDS | 5.81e-04 | 15 | 34 | 2 | M27126 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 6.63e-04 | 16 | 34 | 2 | M8516 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 6.82e-04 | 72 | 34 | 3 | M9257 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 8.43e-04 | 18 | 34 | 2 | M26942 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 1.57e-03 | 96 | 34 | 3 | M26973 | |
| Pathway | KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG | 1.64e-03 | 25 | 34 | 2 | M18312 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 1.64e-03 | 25 | 34 | 2 | M47623 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 1.77e-03 | 26 | 34 | 2 | MM15190 | |
| Pathway | WP_7OXOC_AND_7BETAHC_PATHWAYS | 1.91e-03 | 27 | 34 | 2 | M40054 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.91e-03 | 27 | 34 | 2 | M26943 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.98e-03 | 104 | 34 | 3 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.03e-03 | 105 | 34 | 3 | MM14842 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 2.51e-03 | 31 | 34 | 2 | M39476 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.83e-03 | 118 | 34 | 3 | M27316 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 2.84e-03 | 33 | 34 | 2 | M4086 | |
| Pathway | KEGG_CYSTEINE_AND_METHIONINE_METABOLISM | 3.02e-03 | 34 | 34 | 2 | M10911 | |
| Pathway | REACTOME_MATURATION_OF_SPIKE_PROTEIN | 3.57e-03 | 37 | 34 | 2 | M41728 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 1417950 | ||
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 2.47e-09 | 3 | 48 | 3 | 31645370 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 24045421 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 32987105 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 3346244 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 22217847 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 2765478 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 2415518 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 2733794 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 8297477 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 2.47e-09 | 3 | 48 | 3 | 22890016 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 8188299 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 8484736 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 8250953 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 2703500 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 9408084 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 7565685 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 10490589 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 9.86e-09 | 4 | 48 | 3 | 1970547 | |
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 7668294 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 8587134 | ||
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 9630227 | ||
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 14630516 | ||
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 37838304 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 29968852 | ||
| Pubmed | 1.65e-06 | 17 | 48 | 3 | 27197076 | ||
| Pubmed | Expression of CYP2A genes in human liver and extrahepatic tissues. | 1.87e-06 | 2 | 48 | 2 | 10353262 | |
| Pubmed | Expression and alternative splicing of the cytochrome P-450 CYP2A7. | 1.87e-06 | 2 | 48 | 2 | 7864805 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12012276 | ||
| Pubmed | Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver. | 1.87e-06 | 2 | 48 | 2 | 28298240 | |
| Pubmed | Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice. | 1.87e-06 | 2 | 48 | 2 | 6309775 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 7900999 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12325023 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27520560 | ||
| Pubmed | Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. | 1.87e-06 | 2 | 48 | 2 | 15930087 | |
| Pubmed | Two members of an HNF1 homeoprotein family are expressed in human liver. | 1.87e-06 | 2 | 48 | 2 | 1677179 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21418183 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15111528 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 10484768 | ||
| Pubmed | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | 1.87e-06 | 2 | 48 | 2 | 22696418 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22262919 | ||
| Pubmed | USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. | 1.87e-06 | 2 | 48 | 2 | 20549504 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 30876690 | ||
| Pubmed | Scanning for MODY5 gene mutations in Chinese early onset or multiple affected diabetes pedigrees. | 1.87e-06 | 2 | 48 | 2 | 15660195 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16443774 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21395539 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25635819 | ||
| Pubmed | Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. | 1.87e-06 | 2 | 48 | 2 | 12162851 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 1302041 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8395817 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22160269 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15142986 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18399756 | ||
| Pubmed | Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice. | 1.87e-06 | 2 | 48 | 2 | 25804444 | |
| Pubmed | Genetic variation between mice in their metabolism of coumarin and its derivatives. | 1.87e-06 | 2 | 48 | 2 | 566237 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 1520280 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19923441 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23917075 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12499123 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 2044952 | ||
| Pubmed | Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. | 1.87e-06 | 2 | 48 | 2 | 30222954 | |
| Pubmed | CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. | 1.87e-06 | 2 | 48 | 2 | 16636685 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16297991 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8611142 | ||
| Pubmed | Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver. | 1.87e-06 | 2 | 48 | 2 | 7543189 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27902773 | ||
| Pubmed | Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver. | 1.87e-06 | 2 | 48 | 2 | 22497566 | |
| Pubmed | Characterization and regulation of sex-specific mouse steroid hydroxylase genes. | 1.87e-06 | 2 | 48 | 2 | 2372744 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17855651 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 665441 | ||
| Pubmed | The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. | 1.87e-06 | 2 | 48 | 2 | 2322567 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 14583183 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21473878 | ||
| Pubmed | Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors. | 1.87e-06 | 2 | 48 | 2 | 27059371 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16828057 | ||
| Pubmed | Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene. | 1.87e-06 | 2 | 48 | 2 | 24104196 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20633866 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 7581481 | ||
| Pubmed | The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. | 1.87e-06 | 2 | 48 | 2 | 26363552 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 30154104 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 2712571 | ||
| Pubmed | 2.43e-06 | 638 | 48 | 8 | 31182584 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 2.77e-06 | 20 | 48 | 3 | 9890157 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 18602936 | ||
| Pubmed | Mst1/2 Is Necessary for Satellite Cell Differentiation to Promote Muscle Regeneration. | 5.59e-06 | 3 | 48 | 2 | 35511870 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 18068688 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 18351441 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 16793932 | ||
| Pubmed | Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes. | 5.59e-06 | 3 | 48 | 2 | 19924231 | |
| Pubmed | Variants in MODY genes associated with maternal lipids profiles in second trimester of pregnancy. | 5.59e-06 | 3 | 48 | 2 | 28591938 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 11960914 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 3219345 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17923767 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 1973143 | ||
| Pubmed | Zfp30, a KRAB domain containing zinc finger protein gene, maps to mouse chromosome 7. | 5.59e-06 | 3 | 48 | 2 | 7849402 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20979532 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21252290 | ||
| Pubmed | Mitochondrial targeting of bilirubin regulatory enzymes: An adaptive response to oxidative stress. | 5.59e-06 | 3 | 48 | 2 | 25478736 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20840855 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 26669242 | ||
| Interaction | CYP2A7 interactions | 1.11e-08 | 3 | 46 | 3 | int:CYP2A7 | |
| Cytoband | 19q13.2 | 6.88e-04 | 164 | 48 | 3 | 19q13.2 | |
| Cytoband | Xq25 | 8.55e-04 | 41 | 48 | 2 | Xq25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq25 | 1.17e-03 | 48 | 48 | 2 | chrXq25 | |
| Cytoband | 17q12 | 4.87e-03 | 99 | 48 | 2 | 17q12 | |
| GeneFamily | HNF class homeoboxes | 7.45e-06 | 3 | 29 | 2 | 524 | |
| GeneFamily | Cytochrome P450 family 2 | 2.35e-05 | 35 | 29 | 3 | 1001 | |
| GeneFamily | Ubiquitin specific peptidases | 3.63e-03 | 56 | 29 | 2 | 366 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.51e-05 | 856 | 46 | 9 | M4500 | |
| Coexpression | WENG_POR_DOSAGE | 1.99e-05 | 30 | 46 | 3 | MM1199 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP | 2.62e-05 | 200 | 46 | 5 | M4299 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 188 | 48 | 5 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 190 | 48 | 5 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.80e-05 | 145 | 48 | 4 | 1e52e3c615b49e7388cd58a04e74cafac9552447 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.92e-05 | 164 | 48 | 4 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-05 | 174 | 48 | 4 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.85e-05 | 176 | 48 | 4 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 186 | 48 | 4 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 187 | 48 | 4 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 187 | 48 | 4 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.98e-05 | 188 | 48 | 4 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 5.18e-05 | 190 | 48 | 4 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 5.29e-05 | 191 | 48 | 4 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 192 | 48 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-05 | 193 | 48 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.51e-05 | 193 | 48 | 4 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 193 | 48 | 4 | 605fc2a25ed6846fb283b2918cfed98df6039d6b | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.51e-05 | 193 | 48 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 198 | 48 | 4 | e3d1c9428ee6f9bcf9cdaf2192d4ebea8cc2a47c | |
| ToppCell | distal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.20e-05 | 199 | 48 | 4 | 8f0a72a95d0310ef2324c6975495c294b5a47cc8 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Club|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.20e-05 | 199 | 48 | 4 | 111cfd589ec6795075d8d88d7664bfb23eba5bf6 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-05 | 199 | 48 | 4 | d583290a1d288b749ad17bc501c1487268c6551c | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.20e-05 | 199 | 48 | 4 | 2b17694cffbec28a2c8f165dfcff6bab94aa0f4c | |
| ToppCell | distal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.20e-05 | 199 | 48 | 4 | 685cefbe6ff5db8b578e50b5849524ac2f347d0c | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.33e-05 | 200 | 48 | 4 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| Drug | 2'-methoxyacetophenone | 8.24e-09 | 3 | 47 | 3 | CID000068481 | |
| Drug | diosmetin | 8.73e-07 | 85 | 47 | 5 | CID005281612 | |
| Drug | bromobenzene | 1.68e-06 | 97 | 47 | 5 | CID000007961 | |
| Drug | N-nitrosomethylaniline | 2.95e-06 | 14 | 47 | 3 | CID000011957 | |
| Drug | proadifen hydrochloride | 3.74e-06 | 114 | 47 | 5 | CID000004910 | |
| Drug | nicotine imine | 4.17e-06 | 2 | 47 | 2 | ctd:C034629 | |
| Drug | propargyl ether | 4.17e-06 | 2 | 47 | 2 | ctd:C531209 | |
| Drug | alpha-nicotyrine | 4.17e-06 | 2 | 47 | 2 | ctd:C008615 | |
| Drug | Hempa | 4.17e-06 | 2 | 47 | 2 | ctd:D006492 | |
| Drug | N-nitrosoguvacoline | 4.17e-06 | 2 | 47 | 2 | ctd:C036676 | |
| Drug | potassium citrate | 4.53e-06 | 16 | 47 | 3 | CID000013344 | |
| Drug | hydride | LDHAL6B CYP2A6 CYP2A7 NCOA6 CYP2A13 ACOT8 PAX7 MAN2A1 LDHAL6A MED1 | 6.30e-06 | 835 | 47 | 10 | CID000000783 |
| Drug | N-(3,5-dichlorophenyl)-2-hydroxysuccinimide | 6.58e-06 | 18 | 47 | 3 | CID000114902 | |
| Drug | NAPQI | 7.63e-06 | 61 | 47 | 4 | CID000039763 | |
| Drug | chlorzoxazone | 8.68e-06 | 63 | 47 | 4 | CID000002733 | |
| Drug | 2-ethylhexanol | 1.24e-05 | 22 | 47 | 3 | CID000007720 | |
| Drug | NSC35549 | 1.24e-05 | 22 | 47 | 3 | CID000411697 | |
| Drug | 4-bromophenol | 1.32e-05 | 70 | 47 | 4 | CID000007808 | |
| Drug | bromide | 1.76e-05 | 267 | 47 | 6 | CID000000259 | |
| Drug | C14845 | 2.33e-05 | 27 | 47 | 3 | CID011954064 | |
| Drug | BP-9,10-oxide | 2.33e-05 | 27 | 47 | 3 | CID000037456 | |
| Drug | Brn 4136738 | 2.33e-05 | 27 | 47 | 3 | CID000050331 | |
| Drug | NMPA | 2.50e-05 | 4 | 47 | 2 | CID000132101 | |
| Drug | N'-nitrosoanatabine | 2.50e-05 | 4 | 47 | 2 | ctd:C032978 | |
| Drug | 9-OH-BaP-4,5-oxide | 2.60e-05 | 28 | 47 | 3 | CID000115064 | |
| Drug | N-nitrosodibutylamine | 2.60e-05 | 28 | 47 | 3 | CID000013542 | |
| Drug | androst-16-en-3-one | 2.60e-05 | 28 | 47 | 3 | CID000086705 | |
| Drug | difluorophosphine | 2.90e-05 | 29 | 47 | 3 | CID000139636 | |
| Drug | 11-H-14,15-EETA | 3.22e-05 | 30 | 47 | 3 | CID011954058 | |
| Drug | 19-hydroxytestosterone | 3.22e-05 | 30 | 47 | 3 | CID000150968 | |
| Drug | mephenytoin | 3.27e-05 | 88 | 47 | 4 | CID000004060 | |
| Drug | rifampicin | 3.79e-05 | 306 | 47 | 6 | CID005381226 | |
| Drug | BP-7,8-oxide | 3.92e-05 | 32 | 47 | 3 | CID000037455 | |
| Drug | spirobishexahydropyrimidine | 4.15e-05 | 5 | 47 | 2 | CID000100750 | |
| Drug | AC1O5TJF | 4.15e-05 | 5 | 47 | 2 | CID006440410 | |
| Drug | 1,4-diethoxybutane | 4.15e-05 | 5 | 47 | 2 | CID000232578 | |
| Drug | S-lac-NAD | 4.15e-05 | 5 | 47 | 2 | CID000194292 | |
| Drug | sorbarin | 4.15e-05 | 5 | 47 | 2 | CID009824100 | |
| Drug | acetylphosphonic acid | 4.15e-05 | 5 | 47 | 2 | CID000081311 | |
| Drug | NSC-60195 | 4.15e-05 | 5 | 47 | 2 | CID000020481 | |
| Drug | ethyl gossypol | 4.15e-05 | 5 | 47 | 2 | CID000374353 | |
| Drug | AC1O5ZB9 | 4.15e-05 | 5 | 47 | 2 | CID006443605 | |
| Drug | AC1L49DG | 4.15e-05 | 5 | 47 | 2 | CID000152931 | |
| Drug | N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide | 4.15e-05 | 5 | 47 | 2 | ctd:C062567 | |
| Drug | benzyl selenocyanate | 4.15e-05 | 5 | 47 | 2 | ctd:C054108 | |
| Drug | oxyayanin A | 4.15e-05 | 5 | 47 | 2 | CID005281676 | |
| Drug | B-HAD | 4.15e-05 | 5 | 47 | 2 | CID000131338 | |
| Drug | SQ 31,486 | 4.15e-05 | 5 | 47 | 2 | CID000130015 | |
| Drug | N-trifluoroacetyl-glycine | 4.15e-05 | 5 | 47 | 2 | CID000136227 | |
| Drug | BMS-188107 | 4.15e-05 | 5 | 47 | 2 | CID000192297 | |
| Drug | chrysotile | 4.31e-05 | 33 | 47 | 3 | CID000025477 | |
| Drug | AC1Q6L57 | 4.72e-05 | 34 | 47 | 3 | CID000090740 | |
| Drug | 12(13)-EpOME | 4.72e-05 | 34 | 47 | 3 | CID000001416 | |
| Drug | TCEO | 4.72e-05 | 34 | 47 | 3 | CID000028167 | |
| Drug | AC1O5XSP | 4.72e-05 | 34 | 47 | 3 | CID006442739 | |
| Drug | AC1L1CJI | 5.15e-05 | 35 | 47 | 3 | CID000001929 | |
| Drug | tolbutamide | 5.39e-05 | 198 | 47 | 5 | CID000005505 | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 7398_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 6969_DN | |
| Drug | 15-H-11,12-EETA | 5.61e-05 | 36 | 47 | 3 | CID011954042 | |
| Drug | AC1L3NGJ | 5.61e-05 | 36 | 47 | 3 | CID000092121 | |
| Drug | hexamethylphosphoramide | 5.61e-05 | 36 | 47 | 3 | CID000012679 | |
| Drug | beta-naphthoflavone | 5.65e-05 | 200 | 47 | 5 | CID000002361 | |
| Drug | acenaphthene-1-ol | 6.22e-05 | 6 | 47 | 2 | ctd:C023723 | |
| Drug | AC1L24G8 | 6.22e-05 | 6 | 47 | 2 | CID000066023 | |
| Drug | BL-443 | 6.22e-05 | 6 | 47 | 2 | CID000054436 | |
| Drug | oxymethacil | 6.22e-05 | 6 | 47 | 2 | CID000096369 | |
| Drug | dansyl-L-lysine | 6.22e-05 | 6 | 47 | 2 | CID000598797 | |
| Drug | I 65 | 6.22e-05 | 6 | 47 | 2 | CID000149068 | |
| Drug | D 701 | 6.22e-05 | 6 | 47 | 2 | CID003051460 | |
| Drug | 2,3-dihydroxy-1-naphthoic acid | 6.22e-05 | 6 | 47 | 2 | CID000028002 | |
| Drug | AC1L196J | 6.22e-05 | 6 | 47 | 2 | CID000000415 | |
| Drug | menthofuran | 6.22e-05 | 6 | 47 | 2 | ctd:C054487 | |
| Drug | SQ 32,926 | 6.22e-05 | 6 | 47 | 2 | CID000131363 | |
| Drug | N'-nitrosoanabasine | 6.22e-05 | 6 | 47 | 2 | ctd:C010257 | |
| Drug | diphenyl diselenide | 6.61e-05 | 38 | 47 | 3 | CID000015460 | |
| Drug | 11,14,15-THET | 7.15e-05 | 39 | 47 | 3 | CID006439531 | |
| Drug | GDCA | 8.32e-05 | 41 | 47 | 3 | CID000003493 | |
| Drug | N-acetyl-9-O-lactylneuraminic acid | 8.70e-05 | 7 | 47 | 2 | CID000191486 | |
| Drug | didesmethylcitalopram | 8.70e-05 | 7 | 47 | 2 | CID000162976 | |
| Drug | sodium glycolate | 8.70e-05 | 7 | 47 | 2 | CID000517347 | |
| Drug | AC1O7170 | 8.70e-05 | 7 | 47 | 2 | CID006540699 | |
| Drug | AC1NSM0G | 8.70e-05 | 7 | 47 | 2 | CID005365671 | |
| Drug | BS35 | 8.70e-05 | 7 | 47 | 2 | CID000029316 | |
| Drug | BS36 | 8.70e-05 | 7 | 47 | 2 | CID000029308 | |
| Drug | pentabromoacetone | 8.70e-05 | 7 | 47 | 2 | CID000065579 | |
| Drug | acenaphthene | 8.70e-05 | 7 | 47 | 2 | ctd:C042552 | |
| Drug | methyl-4-hydroxy-3-nitrobenzimidate | 8.70e-05 | 7 | 47 | 2 | CID005492576 | |
| Drug | gossylic iminolactone | 8.70e-05 | 7 | 47 | 2 | CID005479302 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 8.94e-05 | 42 | 47 | 3 | CID006439610 | |
| Drug | polybrominated biphenyl | 1.03e-04 | 44 | 47 | 3 | CID000042948 | |
| Drug | Co-protoporphyrin IX | 1.03e-04 | 118 | 47 | 4 | CID000004972 | |
| Drug | benzphetamine | 1.06e-04 | 119 | 47 | 4 | CID000002341 | |
| Drug | naphthalene-1,2-dihydrodiol | 1.10e-04 | 45 | 47 | 3 | CID000000362 | |
| Drug | 3-methylcholanthrene | 1.12e-04 | 231 | 47 | 5 | CID000001674 | |
| Drug | U75412E | 1.16e-04 | 8 | 47 | 2 | CID003035460 | |
| Drug | AC1Q3O0A | 1.16e-04 | 8 | 47 | 2 | CID000060880 | |
| Drug | UR-12633 | 1.16e-04 | 8 | 47 | 2 | CID000128030 | |
| Drug | p-(phenoxypropoxy)aniline | 1.16e-04 | 8 | 47 | 2 | CID000423258 | |
| Drug | 2-methyl-2-pentenoate | 1.16e-04 | 8 | 47 | 2 | CID000018458 | |
| Disease | C-reactive protein measurement | NPC1 AKAP6 CYP2A6 CYP2A7 NCOA6 HNF1A HNF1B ZNF536 FUT2 CIT DNAH11 | 2.28e-06 | 1206 | 47 | 11 | EFO_0004458 |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.34e-05 | 215 | 47 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.62e-05 | 220 | 47 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.17e-05 | 229 | 47 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | RENAL CELL CARCINOMA, NONPAPILLARY | 5.19e-05 | 7 | 47 | 2 | 144700 | |
| Disease | level of Sphingomyelin (d36:2) in blood serum | 5.19e-05 | 7 | 47 | 2 | OBA_2045177 | |
| Disease | Nonpapillary renal cell carcinoma | 5.19e-05 | 7 | 47 | 2 | cv:CN074294 | |
| Disease | comparative body size at age 10, self-reported | 5.26e-05 | 420 | 47 | 6 | EFO_0009819 | |
| Disease | very low density lipoprotein cholesterol measurement | 5.79e-05 | 260 | 47 | 5 | EFO_0008317 | |
| Disease | total phospholipids in lipoprotein particles measurement | 8.39e-05 | 53 | 47 | 3 | EFO_0022315 | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 8.88e-05 | 9 | 47 | 2 | OBA_2045190 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.27e-04 | 713 | 47 | 7 | EFO_0005689 | |
| Disease | alcohol consumption measurement | 1.29e-04 | 1242 | 47 | 9 | EFO_0007878 | |
| Disease | nicotine metabolite ratio | 1.62e-04 | 12 | 47 | 2 | EFO_0007794 | |
| Disease | Maturity onset diabetes mellitus in young | 2.23e-04 | 14 | 47 | 2 | C0342276 | |
| Disease | serum urea measurement | 2.64e-04 | 195 | 47 | 4 | EFO_0009795 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.75e-04 | 197 | 47 | 4 | EFO_0005680 | |
| Disease | Tremor, Rubral | 2.94e-04 | 16 | 47 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.94e-04 | 16 | 47 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.94e-04 | 16 | 47 | 2 | C0278161 | |
| Disease | Abnormal coordination | 2.94e-04 | 16 | 47 | 2 | C0520966 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 2.94e-04 | 16 | 47 | 2 | OBA_2045195 | |
| Disease | Ataxia, Truncal | 2.94e-04 | 16 | 47 | 2 | C0427190 | |
| Disease | Monogenic diabetes | 2.94e-04 | 16 | 47 | 2 | C3888631 | |
| Disease | Ataxia, Sensory | 2.94e-04 | 16 | 47 | 2 | C0240991 | |
| Disease | liver fibrosis measurement | 3.53e-04 | 86 | 47 | 3 | EFO_0010576 | |
| Disease | cholelithiasis | 3.78e-04 | 88 | 47 | 3 | EFO_0004799 | |
| Disease | level of Sphingomyelin (d38:2) in blood serum | 4.17e-04 | 19 | 47 | 2 | OBA_2045179 | |
| Disease | caffeine metabolite measurement | 4.17e-04 | 19 | 47 | 2 | EFO_0007872 | |
| Disease | serum alanine aminotransferase measurement | 4.22e-04 | 869 | 47 | 7 | EFO_0004735 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.46e-04 | 224 | 47 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | disease of metabolism (implicated_via_orthology) | 5.12e-04 | 21 | 47 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Coronary heart disease | 6.70e-04 | 24 | 47 | 2 | C0010068 | |
| Disease | gallstones | 6.88e-04 | 108 | 47 | 3 | EFO_0004210 | |
| Disease | remnant cholesterol measurement | 6.88e-04 | 108 | 47 | 3 | EFO_0010815 | |
| Disease | Ataxia | 7.28e-04 | 25 | 47 | 2 | C0004134 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 7.88e-04 | 26 | 47 | 2 | OBA_2045194 | |
| Disease | antihyperlipidemic drug use measurement | 8.25e-04 | 115 | 47 | 3 | EFO_0803367 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 8.89e-04 | 118 | 47 | 3 | EFO_0010119 | |
| Disease | TYPE 2 DIABETES MELLITUS | 9.14e-04 | 28 | 47 | 2 | 125853 | |
| Disease | Type 2 diabetes mellitus | 9.14e-04 | 28 | 47 | 2 | cv:C0011860 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 9.33e-04 | 120 | 47 | 3 | EFO_0004611, EFO_0004639 | |
| Disease | creatinine measurement | 9.40e-04 | 995 | 47 | 7 | EFO_0004518 | |
| Disease | Cleft palate, cleft lip | 1.01e-03 | 279 | 47 | 4 | EFO_0003959, HP_0000175 | |
| Disease | Papillary Renal Cell Carcinoma | 1.12e-03 | 128 | 47 | 3 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.12e-03 | 128 | 47 | 3 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.12e-03 | 128 | 47 | 3 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.12e-03 | 128 | 47 | 3 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.12e-03 | 128 | 47 | 3 | C1266044 | |
| Disease | esterified cholesterol measurement | 1.12e-03 | 128 | 47 | 3 | EFO_0008589 | |
| Disease | choline measurement | 1.18e-03 | 130 | 47 | 3 | EFO_0010116 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.27e-03 | 33 | 47 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.37e-03 | 137 | 47 | 3 | EFO_0004611, EFO_0008591 | |
| Disease | phospholipid measurement | 1.45e-03 | 140 | 47 | 3 | EFO_0004639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQPSPMQHQFSMPTV | 131 | O14734 | |
| EMFSSVMKHLPGPQQ | 221 | P11509 | |
| RNMPVNHQFPLASSM | 11 | O75815 | |
| HVVLNKNMPFTSGNM | 621 | Q96DT5 | |
| RPMSDPGVFSQHQAM | 2486 | O75179 | |
| NPHQNMNRGMEFIAP | 71 | Q8WU49 | |
| GMQMHPVQSQASFPK | 1446 | Q9BXF3 | |
| FQGKPPFMTQQQMSP | 31 | O14578 | |
| EMLHGMAPQQKHGQQ | 191 | Q5VWP3 | |
| MNPAAPSNHMNPVSN | 366 | P23759 | |
| QGSMVTQHGKPMFTQ | 161 | Q86U70 | |
| SLMNHPVIPMANKFS | 1011 | Q16706 | |
| EHMKFPMGTQTNPAR | 1591 | P12107 | |
| LNPKQFMTMFPHTPD | 421 | Q3V5L5 | |
| TMDLQHGSPFTKMPN | 111 | Q9BYZ2 | |
| MFGTPQEHRNMPQAD | 271 | Q9HCD5 | |
| QSPFMATMAQLQSPH | 486 | P20823 | |
| DFPVHGMEPMNNATK | 211 | O15118 | |
| PQMSNPGQFTAPQMK | 391 | Q14686 | |
| IGSFGNHPSMMTINN | 216 | Q6AI39 | |
| EMFSSVMKHLPGPQQ | 221 | Q16696 | |
| EMFSSVMKHLPGPQQ | 221 | P20853 | |
| AKMNGRPAFIPAQMH | 86 | Q10981 | |
| NDMGSIPEHKPFQGM | 201 | Q06889 | |
| PQPMQSTAGFMNALH | 266 | P14651 | |
| SMPNLFGQMPMGTHT | 891 | Q8TEH3 | |
| FFKLQQHQSMPGTMA | 536 | Q9NV70 | |
| PVSSMAGNTKNHPML | 631 | Q15648 | |
| ATQFMPDPKLMDHGQ | 241 | Q6UXV4 | |
| GMVGLSKMHAQPPQQ | 281 | Q10571 | |
| LMQQSPGSHMAQQPF | 486 | P35680 | |
| PGSHMAQQPFMAAVT | 491 | P35680 | |
| SHLMKRMSQNFPNGG | 861 | O43147 | |
| HMPFLKNNPKVTGMT | 1301 | Q13023 | |
| SGMVAPSNIFHQPMA | 2446 | Q8IWZ3 | |
| APPKSGKMNMNILHQ | 21 | Q8IWZ8 | |
| NQNMHEPFPMSKNVF | 411 | Q13188 | |
| QQLNMNSAPTFMHFP | 141 | Q13454 | |
| MVAMGTHANAQMPTP | 186 | A0A0J9YY54 | |
| PMTAPQMSRCDQGHK | 2421 | Q8N2C7 | |
| VMPQKMVPLGDSNSH | 426 | A0A0J9YWL9 | |
| EKAHVPMSGQPMGSQ | 66 | O15090 | |
| PQNIQDQAKHMGVMA | 336 | Q99541 | |
| KNFTNGMVNGHMPSL | 851 | P35125 | |
| TEKNFTNGMVNGHMP | 1051 | Q8NFA0 | |
| MAVAPSFNMTNPQPA | 1 | Q2M3C6 | |
| NSVNMPGMVTHIKAP | 1091 | O75962 | |
| VAMQMPVSTSHPNKQ | 306 | Q8N8K9 | |
| QHGSPFMKMPNIVSS | 66 | Q6ZMR3 |